Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RWD domain containing 2B pseudogene (ENSG00000249525) represents a non-functional, non-coding genomic sequence in the human genome that has sequence similarity to the protein-coding RWDD2B gene but lacks the ability to produce a functional protein due to accumulated mutations and absence of essential regulatory elements[1][2][5][8]. Pseudogenes, such as this, are often referred to as “junk DNA”; they may result from gene duplication or retrotransposition of mRNA and are not transcribed into functional proteins[5][8]. No evidence supports any involvement in signaling, receptor activity, disease, drug interaction, or biomarker utility[1][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RWD domain containing 2B pseudogene (RWDD2B pseudogene).